High-Dose-Rate Intraoperative Radiation Therapy for Recurrent Head-and-Neck Cancer
Carcinoma, Squamous Cell
Head and Neck Neoplasms
Neoplasm Recurrence, Local
HDR-IORT has shown encouraging local control outcomes in patients with recurrent HNC with acceptable rates of treatment-related morbidity. Longer follow-up with a larger cohort of patients is needed to fully assess the benefit of this procedure.